Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: TNBC - Triple-Negative Breast Cancer
Interventions: DRUG: Alkaline Glucosodiene Molecules
Sponsor: Ministry of Health, Saudi Arabia
Collaborators: Maher M.akl